Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine ...
Novavax said on Tuesday it ​was entering into a licensing agreement with Pfizer ‌for a substance that helps in boosting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback